pioglitazone has been researched along with Antibiotic-Associated Colitis in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viladomiu, M | 1 |
| Hontecillas, R | 1 |
| Pedragosa, M | 1 |
| Carbo, A | 1 |
| Hoops, S | 1 |
| Michalak, P | 1 |
| Michalak, K | 1 |
| Guerrant, RL | 1 |
| Roche, JK | 1 |
| Warren, CA | 1 |
| Bassaganya-Riera, J | 1 |
1 other study available for pioglitazone and Antibiotic-Associated Colitis
| Article | Year |
|---|---|
Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile.
Topics: Analysis of Variance; Animals; Base Sequence; Clostridioides difficile; Colon; DNA Primers; Enteroco | 2012 |